-
601
Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy
Published 2021-03-01“…Background High-mobility group box 1 (HMGB1) is a multifunctional redox-sensitive protein involved in various intracellular (eg, chromatin remodeling, transcription, autophagy) and extracellular (inflammation, autoimmunity) processes. Regarding its role in cancer development/progression, paradoxical results exist in the literature and it is still unclear whether HMGB1 mainly acts as an oncogene or a tumor suppressor.Methods HMGB1 expression was first assessed in tissue specimens (n=359) of invasive breast, lung and cervical cancer and the two distinct staining patterns detected (nuclear vs cytoplasmic) were correlated to the secretion profile of malignant cells, patient outcomes and the presence of infiltrating immune cells within tumor microenvironment. …”
Get full text
Article -
602
IL-23 tunes inflammatory functions of human mucosal-associated invariant T cells
Published 2025-02-01“…IL-23, in particular, affects key molecules and pathways related to autoimmunity and cytotoxic functions. Integrated analysis of transcriptomes and chromatin accessibility, supported by CRISPR-Cas9 mediated deletion, shows that AP-1 transcription factors constitute a key regulatory node of the IL-23 pathway in MAIT cells. …”
Get full text
Article -
603
Characterization of a WAS splice-site variant in a patient with Wiskott-Aldrich syndrome
Published 2025-01-01“…Wiskott-Aldrich syndrome (WAS) (MIM #301000) is a rare X-linked primary immunodeficiency due to mutations in the WAS gene, characterized by thrombocytopenia with small platelets, eczema, recurrent infections, and an increased incidence of autoimmunity and malignancies. A wide spectrum of mutations has been identified in the WAS gene responsible for a broad variety of clinical phenotypes. …”
Get full text
Article -
604
PD-1 Inhibitor Therapy in a Patient with Preexisting P-ANCA Vasculitis: A Case Report and Review of the Literature
Published 2020-01-01“…As a result, patients with preexisting autoimmune diseases are excluded from studies involving these drugs. …”
Get full text
Article -
605
The Homogeneous Multiplexed System-a New Method for Autoantibody Profile in Systemic Lupus Erythematosus
Published 2005-01-01“…Systemic lupus erythematosus (SLE) is a multi-systemic autoimmune disease leading to immunological aberrations and excessive multiple autoantibody production. …”
Get full text
Article -
606
-
607
Impact of Population Stratification on Family-Based Association in an Admixed Population
Published 2015-01-01Get full text
Article -
608
The Impact of Osteopontin Gene Variations on Multiple Sclerosis Development and Progression
Published 2012-01-01Get full text
Article -
609
Refractory Immunological Thrombocytopenia Purpura and Splenectomy in Pregnancy
Published 2015-01-01“…Herein, we present a pregnant woman who develops at the first trimester autoimmune thrombocytopenia purpura associated with positive antiphospholipid antibodies. …”
Get full text
Article -
610
NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness
Published 2018-01-01“…This can explain exacerbation or increased susceptibility of patients with one autoimmune disease to develop additional autoimmune syndrome.…”
Get full text
Article -
611
Biological Treatments in Behçet’s Disease: Beyond Anti-TNF Therapy
Published 2014-01-01Get full text
Article -
612
Asbestos and Probable Microscopic Polyangiitis
Published 2004-01-01“…Several inorganic dust lung diseases (pneumoconioses) are associated with autoimmune diseases. Although autoimmune serological abnormalities are common in asbestosis, clinical autoimmune/collagen vascular diseases are not commonly reported. …”
Get full text
Article -
613
Efferocytosis and inflammation: a bibliometric and systematic analysis
Published 2025-02-01“…Keyword analysis identified “activation,” “tam receptors,” “docosahexaenoic acid” “systemic lupus erythematosus,” “myocardial infarction” and “alveolar macrophages” as core topics, indicating a concentrated trend in the mechanism of physiological state and inflammatory diseases such as autoimmune, cardiovascular, and pulmonary diseases. …”
Get full text
Article -
614
Autoantibodies and Liver Disease: Uses and Abuses
Published 2010-01-01“…Confirming whether a patient has autoimmune liver disease is challenging, given its varied presentation and complex definitions. …”
Get full text
Article -
615
Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis
Published 2015-01-01“…Indeed, recent data demonstrate the pathogenic role of Th17 cells in autoimmune disorders. In particular, studies in MS and in its animal model (EAE, experimental autoimmune encephalomyelitis) have revealed a crucial role of Th17 cells in the pathogenesis of autoimmune demyelinating diseases in both mice and humans. …”
Get full text
Article -
616
Coexistence of Neonatal Lupus Erythematous and Sturge–Weber Syndrome
Published 2021-01-01Get full text
Article -
617
Clinical and Pathological Roles of Ro/SSA Autoantibody System
Published 2012-01-01“…Although the presence of these autoantibodies is one of the criteria for the diagnosis and classification of SS, they are also sometimes seen in other systemic autoimmune diseases. In the last few decades, the knowledge of the prevalence of anti-Ro/SSA antibodies in various autoimmune diseases and symptoms has been expanded, and the clinical importance of these antibodies is increasing. …”
Get full text
Article -
618
-
619
-
620
Prevention and Reversal of Diabetes by All-Trans Retinoid Acid and Exendin-4 in NOD Mice
Published 2014-01-01“…It has been shown that all-trans retinoid acid (ATRA) hinders the development of autoimmune diabetes by inducing immune tolerance status. …”
Get full text
Article